Form EFFECT Chemomab Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 10, 2024 |
| Accession Number: | 0001178913-24-003893 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
- 5 Best Crypto Presales as Zcash Hits Its Highest Price in Nearly a Decade
- 100x Multiplier Unlocked? Apeing’s $0.0001 Setup Gains Attention as the Best Crypto Presale in 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
